- CMTA Funds Cutting-Edge Gene Editing Studies for Type 2 CMT
Drs. Bruce Conklin and Luke Judge will use a $653,000 grant from the CMTA to develop the gene-editing technique known as CRISPR for application to CMT2A, 2E and 2F.Read more ... - The 2020 Winter CMTA Report
Be the Change: From attitude to exercise to research, in 2020 our CMTA family is committed to be the change we want to see in the world of CMT.Read more ... - David Coldiron Joins CMTA Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the national patient advocacy organization leading CMT research, today announced the appointment of David Coldiron to its Board of Directors.Read more ... - A Message from Patients to Patients
As you’ll learn from watching this video by two young members of our CMT family, tiredness, exhaustion, fatigue and “sluggishness” are all part of having CMT.Read more ... - Another $500,000 Pledge to Type 2 Research!
Bruce Chizen, a special advisor to the Board of Directors, will match donations to CMT2 research on a one-to-one basis, up to $500,000.Read more ...
When you participate in the Walk 4 CMT campaign, you fund patient programs and treatment research initiatives to better the lives of the the 2.8 million people living with CMT.
In honor of CMTA Board Member Steve O'Donnell's quest for a CMT cure, the Plane Apparel Company will donate $5 from the purchase of each CMT Survivor Tee to the CMTA.